Ben Stedman

Ben Stedman has an extensive work experience in the pharmaceutical and biotechnology industry. Ben has held various manufacturing and supply chain roles in different companies throughout their career.

Most recently, Ben worked as the Vice President of Manufacturing at Vivani Medical since May 2020. Prior to that, they served as a Supply Chain and Outsourcing Consultant at Arcutis Biotherapeutics, Inc. from April to June 2020.

From 2018 to 2020, Ben held the position of Vice President of Manufacturing at Aerami Therapeutics. Before that, they worked as a Manufacturing Consultant at Aimmune Therapeutics from July 2017 to February 2018.

In 2016, Ben joined Coherus BioSciences as the Executive Director of Supply Chain. Prior to that, they worked at Dance Biopharm from 2014 to 2016, first as a Vice President of Manufacturing, and then as a Director of Manufacturing.

Ben gained valuable experience at Allergan / MAP Pharmaceuticals as a Senior Manager of Manufacturing Engineering from 2011 to 2013. Ben also worked at MAP Pharmaceuticals from 2008 to 2010, where they held the positions of Manager of Manufacturing Engineering and Principal Manufacturing Engineer.

Earlier in their career, Ben worked at Nektar from 2004 to 2008, starting as a Senior Manufacturing Engineer and later transitioning to the role of Associate Director of Process Improvement / Six Sigma. Ben also worked as a Manufacturing Engineer at Nektar Therapeutics from 1998 to 2003.

Throughout their career, Ben Stedman has demonstrated expertise in manufacturing, supply chain management, and process improvement within the pharmaceutical and biotechnology industry.

Ben Stedman's education history includes a degree in Manufacturing Engineering from California Polytechnic State University-San Luis Obispo. The specific dates of their enrollment or graduation are not provided. Ben then pursued a Master of Business Administration (MBA) in Manufacturing Engineering from San Jose State University, completing their studies between 1991 and 1995. Ben also holds a Six Sigma Black Belt (CSSBB) certification from Nektar Therapeutics, although the date of obtaining this certification is not specified.